Date published: 2026-2-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

Pin1 Activators

Common Pin1 Activators include, but are not limited to Arsenic(III) oxide CAS 1327-53-3, Curcumin CAS 458-37-7, Quercetin CAS 117-39-5, (-)-Epigallocatechin Gallate CAS 989-51-5 and Lithium CAS 7439-93-2.

Pin1 Activators belong to a distinctive chemical class that has gained attention for their ability to modulate the activity of Pin1, a unique enzyme known as a peptidyl-prolyl cis-trans isomerase. These activators function by influencing the interactions and pathways involving Pin1, which plays a pivotal role in post-translational modification of proteins by catalyzing the isomerization of specific proline residues. This activity, in turn, regulates protein conformation and function, impacting a myriad of cellular processes, including cell cycle progression, signal transduction, gene expression, and cellular response to stress. Pin1 is particularly recognized for its involvement in mediating protein-protein interactions and controlling the fate of phosphorylated proteins, thereby impacting various aspects of cellular physiology. Pin1 Activators are thoughtfully designed to target specific mechanisms or pathways associated with Pin1, thus influencing its cellular functions and downstream effects on cellular signaling and regulation.

The development of Pin1 Activators requires a comprehensive understanding of the structural attributes of Pin1 and its interactions with substrates, target proteins, and other intracellular molecules. Researchers in this field work to engineer molecules that promote the activation of Pin1, contributing to its role in regulating protein function and modulating cellular responses. These activators often employ innovative design strategies that enhance Pin1's functional role in mediating conformational changes and modulating protein-protein interactions. By gaining insights into the intricate mechanisms through which Pin1 participates in cellular processes, researchers aim to unravel its significance in fundamental biological phenomena. Ongoing advancements in molecular pharmacology and chemical synthesis drive the refinement of Pin1 Activators, offering applications across diverse scientific domains where manipulation of Pin1-mediated processes is of interest.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Arsenic(III) oxide

1327-53-3sc-210837
sc-210837A
250 g
1 kg
$89.00
$228.00
(0)

Induces Pin1 expression through Nrf2/ARE pathway

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Upregulates Pin1 expression via multiple pathways

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Induces Pin1 expression through p53-dependent mechanisms

Eicosa-5Z,8Z,11Z,14Z,17Z-pentaenoic Acid (20:5, n-3)

10417-94-4sc-200766
sc-200766A
100 mg
1 g
$104.00
$431.00
(0)

Increases Pin1 expression via effects on lipid metabolism

Quercetin

117-39-5sc-206089
sc-206089A
sc-206089E
sc-206089C
sc-206089D
sc-206089B
100 mg
500 mg
100 g
250 g
1 kg
25 g
$11.00
$17.00
$110.00
$250.00
$936.00
$50.00
33
(2)

Induces Pin1 expression by influencing oxidative stress and NF-κB signaling

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

Upregulates Pin1 expression through modulation of cellular redox status

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Induces Pin1 expression in neurons via GSK-3β inhibition

Salidroside

10338-51-9sc-472942
50 mg
$360.00
1
(0)

Increases Pin1 expression through the PI3K/Akt pathway

Anacardic Acid

16611-84-0sc-202463
sc-202463A
5 mg
25 mg
$102.00
$204.00
13
(1)

Induces Pin1 expression through epigenetic modifications

Indirubin

479-41-4sc-201531
sc-201531A
5 mg
25 mg
$114.00
$525.00
4
(1)

Upregulates Pin1 expression by inhibiting CDKs and GSK-3β